Back to video list Back to Home If optimizing the dose of the current antidepressant is not an effective strategy, at which part of the dose range can we consider adding an augmenting agent? You may also like Alzheimer's Disease Article Reducing risks through life could cut dementia by a third Parkinson's Disease Congress highlights Article Hot topics in Parkinson’s disease research from AAN Virtual 2022 Schizophrenia Article Changing the course of schizophrenia: biology, psychology and livelihood Parkinson's Disease Article Rest Tremor in Parkinson’s disease